Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Acta Myol ; 40(2): 72-87, 2021 Jun.
Article in English | MEDLINE | ID: mdl-34355124

ABSTRACT

Muscular dystrophy (MD) is a group of neuromuscular diseases characterized by progressive muscle weakness due to various mutations in several genes involved in muscle structure and function. The age at onset, evolution and severity of the different forms of MD can vary and there is often impairment of motor function and activities of daily living. Although there have been important scientific advances with regard to pharmacological therapies for many forms of MD, rehabilitation management remains central to ensuring the patient's psychophysical well-being. Here we report the results of an Italian consensus conference promoted by UILDM (Unione Italiana Lotta alla Distrofia Muscolare, the Italian Muscular Dystrophy Association) in order to establish general indications and agreed protocols for motor rehabilitation of the different forms of MD.


Subject(s)
Muscular Dystrophies , Neuromuscular Diseases , Activities of Daily Living , Humans , Muscle Weakness/etiology , Rome
2.
Bioprocess Biosyst Eng ; 44(11): 2361-2374, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34304344

ABSTRACT

An advanced dual-flow perfusion bioreactor with a simple and compact design was developed and evaluated as a potential apparatus to reduce the gap between animal testing and drug administration to human subjects in clinical trials. All the experimental tests were carried out using an ad hoc Poly Lactic Acid (PLLA) scaffold synthesized via Thermally Induced Phase Separation (TIPS). The bioreactor shows a tunable radial flow throughout the microporous matrix of the scaffold. The radial perfusion was quantified both with permeability tests and with a mathematical model, applying a combination of Darcy's Theory, Bernoulli's Equation, and Poiseuille's Law. Finally, a diffusion test allowed to investigate the efficacy of the radial flow using Polymeric Fluorescent Nanoparticles (FNPs) mimicking drug/colloidal carriers. These tests confirmed the ability of our bioreactor to create a uniform distribution of particles inside porous matrices. All the findings candidate our system as a potential tool for drug pre-screening testing with a cost and time reduction over animal models.


Subject(s)
Bioreactors , Nanoparticles/administration & dosage , Animals , Biocompatible Materials , Drug Carriers , Humans , In Vitro Techniques , Microscopy, Electron, Scanning , Polymers/chemistry , Tissue Engineering
3.
Biochem Biophys Res Commun ; 531(2): 223-227, 2020 10 15.
Article in English | MEDLINE | ID: mdl-32798016

ABSTRACT

Anaplastic thyroid carcinoma (ATC) is a rare and aggressive malignancy that accounts for the majority of deaths from all thyroid cancers. ATC exhibits invasiveness and highly resistance to conventional therapies which include cytotoxic chemotherapy, the combination of BRAF and MEK inhibition and, more recently, immunotherapies, that have shown promising but still limited results. A growing knowledge on ATC tumor biology is needed for developing more effective therapies with significant better survival. Researchers have begun to utilize 3D models to culture cancer cells for in vitro studies. In this work, C643 ATC cell line was cultured on polymeric scaffolds with high-interconnected porous matrix. They exhibited distinct viability, proliferation and 3D morphology similar to an in vivo solid tumor mass. We also carried out quantitative real-time PCR experiments for monitoring Cancer Stem Cells enrichment, since they are most probably the cause of tumor resistance, reoccurrence and metastasis. The same tests were performed after cell treatment with the chemotherapic Doxorubicin. An up-regulation of the analyzed stem-cell markers confirmed the high resistance to treatment of these cell line with respect to conventional drugs. In conclusion, 3D scaffolds could be an ideal platform for studying the mechanisms that regulate ACT growth and survival and also improving novel therapeutic approaches for treatment-resistant thyroid cancer.


Subject(s)
Disease Progression , Polymers/chemistry , Thyroid Carcinoma, Anaplastic/pathology , Biomarkers, Tumor/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Shape/drug effects , Doxorubicin/pharmacology , Humans , Neoplastic Stem Cells/drug effects , Neoplastic Stem Cells/metabolism , Neoplastic Stem Cells/pathology , Tissue Scaffolds/chemistry
4.
Neurol Sci ; 41(9): 2561-2567, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32246354

ABSTRACT

Previous studies demonstrated the benefits of motor exercise and physical activity in neuromuscular disorders. However, very few papers assessed the effects of sport practise. The aim of this multicentre study was to assess the impact of sport activity on self-esteem and emotional regulation in a cohort of athletes with neuromuscular disorders. The 38 patients with Duchenne, Becker or other types of muscular dystrophy or spinal muscular atrophy practising sport (aged 13-49 years) and 39 age-, gender-, disability- and disease-matched patients not practising sport were enrolled. Testing procedures to assess self-esteem, anxiety and depression disorder, personality trait and quality of life (QoL) were used. Patients practising sport had a significantly higher self-esteem, lower level of depression, greater social own identity and adherence and QoL. Frequency of sport activity may represent a complementary therapy in neuromuscular disorders to improve mental and social well-being.


Subject(s)
Neuromuscular Diseases , Sports , Adolescent , Adult , Athletes , Humans , Middle Aged , Neuromuscular Diseases/therapy , Quality of Life , Self Concept , Young Adult
5.
Tissue Cell ; 58: 33-41, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31133244

ABSTRACT

The "microenvironment" where a tumor develops plays a fundamental role in determining its progression, the onset of metastasis and, eventually, its resistance to therapies. Tumor cells can be considered more or less invasive depending both on the nature of the cells and on the site where they are located. Commonly adopted laboratory culture protocols for the investigation of tumor cells take usually place on standard two-dimensional supports. However, such cultures do not allow for reproduction of the biophysical properties of the tumor's microenvironment, thus causing the cells to lose most of their relevant characteristics. In this work MDA-MB 231 breast cancer cells were cultivated within Poly-l-Lactic Acid (PLLA) scaffolds produced via Thermally Induced Phase Separation (TIPS). Starting from a ternary solution (polymer-solvent-nonsolvent) we produced scaffolds with different morphologies, porosities and pore architectures. The influence of porosity and average pore size upon cell adhesion and growth were investigated by using Cell Counting Kit-8 (CCK-8) as cell viability test, a fluorescence assay staining cell with DAPI and Scanning Electron Microscopy (SEM). Our study demonstrates that the average pore size of the polymeric scaffolds influences both the cell adhesion and resulting morphology of the growing breast cancer cells. In particular, the reported data corroborate the evidence that an average pore size ranging from 40 to 50 µm induces tumor cell aggregation and the formation of the irregular tumor masses typically observed in-vivo. In addition, TIPS proved to be a suitable manufacturing technique for finely tuning the scaffolds' architecture, relevant to developing the most effective microenvironment for an in-vitro tumor cells growth closely mimicking in-vivo conditions.


Subject(s)
Breast Neoplasms/metabolism , Models, Biological , Polyesters/chemistry , Tissue Scaffolds/chemistry , Tumor Microenvironment , Breast Neoplasms/pathology , Cell Line, Tumor , Female , Humans
6.
Acta Myol ; 36(2): 41-45, 2017 06.
Article in English | MEDLINE | ID: mdl-28781515

ABSTRACT

This paper describes the psycho-social treatments received by 502 patients with MDs and their relatives, and the costs for care sustained by the families in the previous six month period. Data were collected by the MD-Care Schedule (MD-CS) and the Family Problems Questionnaire (FPQ). Psycho-educational interventions were provided to 72 patients (14.3%), and social/welfare support to 331 patients (65.9%). Social/welfare support was higher in patients with DMD or LGMD, in those showing more severe disability, and in patients who were in contact with centres located in Northern Italy. Psycho-educational interventions were received by 156 (31%) relatives, and social/welfare support by 55 (10.9%) and mainly provided by Family/Patients Associations (83.6%). Relatives with higher educational levels, who spent more daily hours in the assistance of patients with DMD, and in contact with centres in Central Italy more frequently benefited from psycho-educational interventions. In the previous year, costs for care were sustained by 314 (63.9%) relatives. Financial difficulties related to patient's condition, were higher in families of patients who needed more intensive rehabilitation and daily hours of caregiving, and in families who lived further away from the reference's centre. These results showed that psycho-social aspects of MDs care are only partially met in Italy, and that ad hoc supportive interventions for these patients and their families should be potentiated.


Subject(s)
Caregivers/psychology , Cost of Illness , Muscular Dystrophies/economics , Muscular Dystrophies/psychology , Psychosocial Support Systems , Social Welfare , Activities of Daily Living , Adolescent , Adult , Child , Child, Preschool , Delivery of Health Care, Integrated , Fees and Charges/statistics & numerical data , Female , Humans , Italy , Male , Middle Aged , Muscular Dystrophies/rehabilitation , Patient Education as Topic , Young Adult
7.
Acta Myol ; 36(1): 19-24, 2017 03.
Article in English | MEDLINE | ID: mdl-28690390

ABSTRACT

This paper describes the pharmacological therapies and rehabilitative interventions received by 502 patients with Muscular Dystrophies, evaluated in relation to patient's socio-demographic and clinical variables, and geographical areas. Data were collected by the MD-Socio-Demographic and Clinical Schedule (MD-SC-CS) and by the Family Problems Questionnaire (FPQ). The most part of the enrolled patients were in drug treatment. The number of the medications increased in relation to patient's age, disability degree and duration of illness and was higher among patients with Duchenne Muscular Dystrophy (DMD) compared with Becker (BMD) or Limb-Girdle Muscular Dystrophies (LGMD). Steroids (deflazacort or prednisone) were the drug most frequently used, followed by cardiologic and bone metabolism drugs. In general, patients using steroids were younger and had a shorter duration of illness; patients using cardiac drugs and dietary supplements were older and had a longer duration of illness. Rehabilitative interventions were provided to about 70% (351/502) of patients, mainly DMD. Of these, physiotherapy was the more frequent treatment (96.6%) and was prevalently performed in rehabilitative centres (about 70% of patients) and at home in only 30%. Hydrokinetic-therapy was practiced by 6.8% of patients. Respiratory rehabilitation was provided to 47.0% of patients (165/351) and assisted mechanical ventilaventilation to 13.1% (46). The amount of rehabilitative interventions increased in relation to the patient's age, level of disability and duration of illness. Compared to Central and Northern Italy, in Southern Italy there was a higher attention to cardiological impairment as shown by a higher number of patients receiving heart drugs. No statistically significant differences concerning the possibility to have access to rehabilitative interventions were noted among the three geographical areas. However, patient living in Southern Italy tend to receive rehabilitation more often at home.


Subject(s)
Glucocorticoids/therapeutic use , Muscular Dystrophies/drug therapy , Muscular Dystrophies/rehabilitation , Physical Therapy Modalities , Adolescent , Age Factors , Bone Density Conservation Agents/therapeutic use , Breathing Exercises , Cardiotonic Agents/therapeutic use , Child , Combined Modality Therapy , Dietary Supplements , Disability Evaluation , Female , Health Care Surveys , Humans , Italy , Male , Prednisone/therapeutic use , Pregnenediones/therapeutic use , Respiration, Artificial , Time Factors
8.
Muscle Nerve ; 52(1): 13-21, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25363165

ABSTRACT

INTRODUCTION: This study explores burden and social and professional support in families of young patients with muscular dystrophies (MDs) in Italy. METHODS: The study was carried out on 502 key relatives of 4- to 25-year-old patients suffering from Duchenne, Becker, or Limb-Girdle MD who were living with at least 1 adult relative. RESULTS: A total of 77.1% of relatives reported feelings of loss, 74.0% had feelings of sadness, and 59.1% had constraints in leisure activities. Burden was higher among relatives of patients with higher disability and who spent more daily hours in caregiving. Practical difficulties were higher among relatives who perceived lower help in patient emergencies and less practical support by their social network. Psychological burden was higher in those relatives who were unemployed, those with poorer support in emergencies, and those with lower social contacts. CONCLUSIONS: Caring for patients with MDs may be demanding for relatives even in the early stages of these disorders, especially when social support is poor and the patient's disability increases.


Subject(s)
Family/psychology , Muscular Dystrophies/economics , Muscular Dystrophies/epidemiology , Professional-Patient Relations , Social Support , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Humans , Italy , Male , Middle Aged , Muscular Dystrophies/therapy , Regression Analysis , Socioeconomic Factors , Surveys and Questionnaires , Young Adult
9.
J Neurol ; 261(1): 188-95, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24202786

ABSTRACT

This paper focuses on the psychological benefits of caregiving in key relatives of patients with muscular dystrophies (MD), a group of rare diseases characterized by progressive weakness and restriction of the patient's functional abilities. We describe whether relatives perceived caregiving to be a positive experience and test whether relatives' perceptions vary in relation to their view of the patient as a valued person, the degree of involvement in care, and the level of support provided by social network and professionals. The study sample included 502 key relatives of patients aged 4-25 years, suffering from Duchenne, Becker, or limb-girdle MD, in treatment for at least 6 months to one of the eight participating centers, living with at least one relative aged 18-80 years. Of key relatives, 88 % stated that they had gotten something positive out of the situation, 96 % considered their patients to be sensitive, and 94 % viewed their patients as talented. Positive aspects of caregiving were more recognized by key relatives who were more convinced that the patient was sensitive and who perceived that they received higher level of professional help and psychological social support. These results suggest that most key relatives consider that their caregiving experience has had a positive impact on their lives, despite the practical difficulties of caring for patients with MD. Professionals should help relatives to identify the benefits of caregiving without denying its difficulties. Clinicians themselves should develop positive attitudes towards family involvement in the care of patients with long-term diseases.


Subject(s)
Caregivers/psychology , Family/psychology , Muscular Dystrophies/nursing , Muscular Dystrophies/psychology , Activities of Daily Living , Adolescent , Adult , Aged , Aged, 80 and over , Analysis of Variance , Child , Child, Preschool , Cost of Illness , Female , Humans , Italy , Male , Middle Aged , Social Support , Stress, Psychological , Surveys and Questionnaires , Young Adult
10.
Acta Myol ; 33(3): 136-43, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25873782

ABSTRACT

This study explored the burden in parents and healthy siblings of 4-17 year-old patients with Duchenne (DMD) and Becker (BMD) muscular dystrophies, and whether the burden varied according to clinical aspects and social resources. Data on socio-demographic characteristics, patient's clinical history, parent and healthy children burden, and on parent's social resources were collected using self-reported questionnaires administered to 336 parents of patients with DMD (246) and BMD (90). Parents of patients with DMD reported higher burden than those of patients with BMD, especially concerning feeling of loss (84.3% DMD vs. 57.4% BMD), stigma (44.2% DMD vs. 5.5% BMD) and neglect of hobbies (69.0% DMD vs. 32.5% BMD). Despite the burden, 66% DMD and 62.4% BMD parents stated the caregiving experience had a positive impact on their lives. A minority of parents believed MD has a negative influence on the psychological well-being (31.0% DMD vs. 12.8% BMD), and social life of unaffected children (25.7% vs. 18.4%). In the DMD group, burden correlated with duration of illness and parent age, and burden was higher among parents with lower social contacts and support in emergencies. In DMD, difficulties among healthy children were reported as higher by parents who were older, had higher burden and lower social contacts. In both groups, burden increased in relation to patient disability. These findings underline that the psychological support to be provided to parents of patients with MD, should take into account clinical features of the disease.


Subject(s)
Caregivers , Family Health , Muscular Dystrophy, Duchenne , Parents/psychology , Siblings/psychology , Adolescent , Adult , Caregivers/psychology , Caregivers/statistics & numerical data , Child , Child, Preschool , Cost of Illness , Family , Humans , Italy , Middle Aged , Muscular Dystrophy, Duchenne/physiopathology , Muscular Dystrophy, Duchenne/psychology , Social Support , Socioeconomic Factors
11.
Neuromuscul Disord ; 23(6): 451-5, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23535446

ABSTRACT

The aim of this study was to assess neurodevelopmental profile in young boys affected by Duchenne muscular dystrophy and to establish the correlation between neurodevelopmental findings, and the type and site of mutations. A structured neurodevelopmental assessment (Griffiths Scale of Mental Development) was performed in 81 DMD boys before the age of four years (range: 7-47 months). The mean total DQ was 87 (SD 15.3). Borderline DQ (between 70 and 84) was found in 32% and DQ below 70 in 12.3% of the patients. Children with mutations upstream or in exon 44 had higher DQ than those with mutations downstream exon 44 which are associated with involvement of dystrophin isoforms expressed at high levels in brain. The difference was significant for total and individual subscale DQ with the exception of the locomotor subscale. Items, such as ability to run fast, or getting up from the floor consistently failed in all children, irrespective of the age or of the site of mutation. Our results help to understand the possible different mechanisms underlying the various aspects of neurodevelopmental delay, suggesting that the involvement of brain dystrophin isoforms may cause a delay in the maturation of coordination and dexterity.


Subject(s)
Chromosome Mapping , Dystrophin/genetics , Muscular Dystrophy, Duchenne/genetics , Mutation/genetics , Child, Preschool , Early Diagnosis , Exons/genetics , Humans , Infant , Male , Muscular Dystrophy, Duchenne/complications , Muscular Dystrophy, Duchenne/metabolism , Protein Isoforms/genetics
12.
J Pediatr ; 161(4): 705-9.e1, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22560791

ABSTRACT

OBJECTIVES: To assess attention deficit hyperactivity disorder (ADHD) in boys affected by Duchenne muscular dystrophy (DMD) and to explore the relationship with cognitive abilities and genetic findings. STUDY DESIGN: Boys with DMD (n = 103; 4-17 years of age, mean: 12.6) were assessed using a cognitive test (Wechsler scales). Assessment of ADHD was based on the Diagnostic Statistical Manual, Fourth Edition, Text Revision criteria and on the long version of the Conners Parents and Teachers Rating Scales. RESULTS: ADHD was found in 33 of the 103 boys with DMD. Attention problems together with hyperactivity (17/33) or in isolation (15/33) were more frequent than hyperactivity alone, which was found in 1 patient. Intellectual disability (ID) was found in 27/103 (24.6%). Sixty-two of the 103 boys had no ID and no ADHD, 9 had ID but no ADHD, 14 had ADHD but no ID, and 18 had both. ADHD occurred more frequently in association with mutations predicted to affect Dp140 expression (exon 45-55) and in those with mutations predicted to affect all dystrophin product, including Dp71 (ie, those that have promoter region and specific first exon between exons 62 and 63 but were also relatively frequent). CONCLUSIONS: Our results suggest that ADHD is a frequent feature in DMD. The risk of ADHD appears to be higher in patients carrying mutations predicted to affect dystrophin isoforms expressed in the brain and are known to be associated with higher risk of cognitive impairment.


Subject(s)
Attention Deficit Disorder with Hyperactivity/epidemiology , Cognition , Muscular Dystrophy, Duchenne/epidemiology , Adolescent , Child , Child, Preschool , Cognition Disorders/epidemiology , Comorbidity , Dystrophin/genetics , Genotype , Humans , Male , Muscular Dystrophy, Duchenne/genetics , Mutation , Phenotype , Prospective Studies , Protein Isoforms
13.
Eur J Paediatr Neurol ; 15(4): 353-60, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21514859

ABSTRACT

BACKGROUND: Late-preterm infants represent 70% of the whole preterm population. AIMS: To establish the range and frequency distribution of neonatal neurological scores in a large cohort of low risk late-preterm infants and the possible differences with full-term infants. METHODS: Three hundred-seventy-five healthy infants born between 34 and 36 weeks gestational age (GA) without major brain lesions were assessed between 39 and 41 weeks post-menstrual age using the Hammersmith Neonatal Neurologic Assessment and compared to the scores obtained using the same examination in full-term infants. RESULTS: Infants born at 35 and 36 weeks GA had similar median scores in 32 of the 34 items. Infants born at 34 weeks GA had a different profile of scores compared to those born at 35 and 36 weeks, mainly in the tone items. While in infants born at 34 weeks the assessment at term age showed similar median scores to those obtained in full-term infants in 25/34 items, in those born at 35 and 36 GA the number of scores similar to full-term infants increased to 29/34. The main differences involved the tone items, with more marked flexor tone in the limbs and better head control for those born at 35 and 36 weeks. CONCLUSIONS: This data can help as reference data when examining late-preterm infants at term age to see where the individual child stands compared to age matched low risk infants and to identify signs that are outside the reported range in infants with lesions or other risk factors.


Subject(s)
Developmental Disabilities/epidemiology , Infant, Premature, Diseases/epidemiology , Infant, Premature/physiology , Neonatal Screening/methods , Brain Diseases/diagnosis , Brain Diseases/epidemiology , Brain Diseases/physiopathology , Cohort Studies , Developmental Disabilities/diagnosis , Developmental Disabilities/physiopathology , Disability Evaluation , Female , Gestational Age , Humans , Infant, Newborn , Infant, Premature, Diseases/diagnosis , Infant, Premature, Diseases/physiopathology , Male , Neurologic Examination/methods , Pregnancy , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...